Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells

Yoolhee Yang1, Jin Ho Paik, Daeho Cho

  • 1Department of Life Science, Sookmyung Women's University, Hyochangwon-gil 52, Yongsan-gu, Seoul 140-742, Republic of Korea.

Insights

Resveratrol, a compound from grapes, suppresses regulatory T cells (Treg cells) and enhances immune responses. This suggests resveratrol could be a valuable adjuvant for cancer immunotherapy.

Area of Science:

  • Immunology
  • Cancer Research
  • Pharmacology

Background:

  • CD4+CD25+ regulatory T cells (Treg cells) suppress immune responses and hinder cancer immunotherapy.
  • Resveratrol, a natural compound, exhibits immunomodulatory and anticancer properties.
  • The role of resveratrol in modulating Treg cells in cancer remains to be fully elucidated.

Purpose of the Study:

  • To investigate the effect of resveratrol on Treg cell populations and immunomodulatory cytokines in a mouse cancer model.
  • To determine if resveratrol's effects are mediated through Treg cell modulation.
  • To assess resveratrol's potential as an adjuvant for cancer therapy.

Main Methods:

  • EG7 tumor-bearing C57BL/6 mice were treated with resveratrol.
  • Flow cytometry (FACS) was used to analyze CD4+CD25+ cell populations and FoxP3 expression.
  • Cytokine levels (TGF-beta and IFN-gamma) were measured in spleen cells.

Main Results:

  • Resveratrol inhibited CD4+CD25+ cell populations ex vivo in a dose-dependent manner.
  • Resveratrol treatment reduced FoxP3+ cells and TGF-beta secretion in vivo.
  • Resveratrol enhanced IFN-gamma expression in CD8+ T cells, indicating immune stimulation.

Conclusions:

  • Resveratrol suppresses Treg cells and downregulates immunosuppressive cytokines in tumor-bearing mice.
  • Resveratrol promotes an anti-tumor immune response by enhancing CD8+ T cell activity.
  • Resveratrol shows promise as an adjuvant material for vaccination-based cancer therapy.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...